0 of 5 questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 5 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. Please list your last name and zip code:
2. What is your specialty?
3. How many patients with IBD do you see each week?
4. The 2017 AGA guidelines recommend therapeutic drug monitoring (TDM) in which of the following situations?
5. Your patient, a 23-year-old male with a new diagnosis of moderate-to-severe Crohn’s colitis, was started on prednisone 40mg and infliximab 5mg/kg. He did well during induction dose; however, after tapering off prednisone, his symptoms recur and fecal calprotectin is 300 on infliximab 5mg/kg every 8 weeks. His infliximab trough level at week 14 is 18 mcg/ml and there are no anti-drug antibodies. C. difficile is negative. What is the next best step?